CRVL vs JAZZ · P/E 29, rev $958.5M vs P/E 1988, rev $2.28B
CorVel Corp (CRVL) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
CorVel Corp (CRVL) is a insurance brokers company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported CRVL revenue for 2026-03-31 was $958.5M. Net income was $110.3M. Revenue was up 7.0% from 2025-03-31 to 2026-03-31. CRVL currently screens at market cap $3.13B and trailing P/E 28.9.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
CRVL currently screens at market cap $3.13B and trailing P/E 28.9. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the CRVL and JAZZ stock pages for the full models.
Not investment advice.